What's New

Media & Press Updates

 

In4Derm announces a strategic partnership with an innovation-driven NASDAQ listed biotech with a >$200m Option License Agreement for first-in-class BET bromodomain therapeutics pipeline.

May 11th 2021

Newborn

In4Derm

Because Skin Matters

 

Our approach

Delivering first in class therapies for skin disease

We specialize in the discovery of drugs, which are safe and effective, for the treatment of skin diseases including ​eczema, non-melanoma skin cancers and orphan skin diseases

By discovering the next generation of therapies, we hope to greatly improve the well-being of patients with these conditions.

​We would love to tell you more so please contact us with your questions.

Scientist in the Lab
 

Get in Touch

In4Derm Ltd. 15 Luke Place, Dundee, DD5 3BN. Company number: SC651132